Brian Kennedy at ARDD2025: Validating and Implementing Longevity interventions

Brian Kennedy at ARDD2025: Validating and Implementing Longevity interventions

by Brian Kennedy

Life & Natural Systems Medicine & Health MFKHHuman growth and developmentMFKH3Maturation and ageing
🎙 Brian Kennedy 👥 9K 📅 January 22, 2026 ⏱ 21 min 👁 287 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

aging clocksmethylationclinical chemistrysupplementslongevity clinics

Summary

Brian Kennedy, a prominent researcher in aging, presents at the 12th Aging Research and Drug Discovery meeting. He discusses two biological aging clocks: a methylation clock and a clinical chemistry clock. For the methylation clock, he analyzes data from a community-based cohort of nearly 4,000 individuals who paid for the test. The data shows that users are generally healthier and biologically younger than their chronological age. He highlights the effects of various supplements and drugs, notably a 5.7-year reduction in biological age associated with the supplement Rejuvant (time-release alpha-ketoglutarate), though the effect size is smaller for generic AKG. He also notes that metformin and rapamycin did not show significant effects on this clock. The clinical chemistry clock, developed with Yan and Fun, uses standard blood biomarkers to predict mortality and is more actionable in clinical settings. It outperforms first-generation methylation clocks and is being validated in diverse populations. Kennedy concludes by discussing challenges in longevity clinics, emphasizing the need for validation, transparency, and client engagement. He advocates for democratizing health data and personalizing interventions, while cautioning against overpromising results.

179 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the practical application of biological clocks and the analysis of real-world data. Kennedy’s argumentation is grounded in his experience and preliminary data, but he acknowledges limitations such as lack of placebo controls and self-reporting biases. He effectively argues for the need to connect interventions, clocks, and outcomes to achieve personalized longevity medicine. The discussion of the clinical chemistry clock’s predictive power and its actionable nature is compelling, though the data is not yet peer-reviewed.

Scientific Rigor, Source Quality, Title Accuracy

Kennedy references specific data sets (NHANES, TruMe cohort) and mentions collaborations with companies and clinics. However, he does not provide detailed citations for the claims, and the presented analyses are preliminary. The title accurately reflects the content, focusing on validation and implementation. The talk is scientifically rigorous in its acknowledgment of limitations, but the lack of published sources for the specific results reduces the overall source quality.

162 words

Title / Content Match

The title accurately reflects the content: the speaker discusses validation of longevity interventions (supplements, clocks) and implementation in clinics.

Quality & Reliability

8/10

Presentation by a recognized expert in aging research, based on preliminary data from a large community cohort and a clinical chemistry clock. Limitations are acknowledged, but the lack of peer review for the presented analyses tempers the score.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • NHANES — Reference for the clinical chemistry clock development and validation.
  • TruMe methylation test — Mentioned as the source of the methylation clock data.

Concurring Sources

Contribution & Novelties

The talk provides a unique perspective on the practical implementation of longevity interventions, using real-world data from a large community cohort. It highlights the potential of clinical chemistry clocks as more actionable tools in clinical settings. The analysis of supplement effects, particularly the time-release AKG, offers new insights, though the data is preliminary.

Pour aller plus loin :

  • Epigenetic clocks — Overview of methylation-based aging clocks.
  • Alpha-ketoglutarate — Background on the compound discussed.
  • NHANES — The dataset used for the clinical chemistry clock.

83 words

Radar Profile

The radar profile shows high scores in information quantity and quality, with slightly lower technical level and reliability, reflecting the preliminary nature of the data and the expert opinion format.

Reliability 7/10